Back

Incheon bio capacity to exceed 2.14 million liters by 2032 amid Korea’s CDO gap

Verifying
  • Incheon began burying 154,000-volt lines for the expanding Songdo biopharmaceutical cluster.
  • 2.14 million liters is Incheon’s projected biopharmaceutical capacity by 2032.
  • Korea’s bio industry faces a CDO gap despite strong contract manufacturing capacity.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Incheon bio capacity to exceed 2.14 million liters by 2032 amid Korea’s CDO gap - CoinPost Terminal